US Buys More Monkeypox Vaccine, Ramps Up Testing as Cases Rise

July 15, 2022, 7:20 PM UTC

The US has ordered another 2.5 million doses of Bavarian Nordic A/S’s Jynneos vaccine that will be available next year as monkeypox continues to spread with more than 1,400 cases reported nationally as of Friday.

The Centers for Disease Control and Prevention expects more infections to be reported in coming days as the government has greatly expanded testing to include several commercial labs, Director Rochelle Walensky said in a press call. The US can now test 70,000 samples a week, up from 6,000, she said.

As cases rise, the demand for vaccines has been much higher than the government’s ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.